Journal of Clinical and Experimental Hematopathology

Scope & Guideline

Catalyzing Global Collaboration in Hematopathology.

Introduction

Explore the comprehensive scope of Journal of Clinical and Experimental Hematopathology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Clinical and Experimental Hematopathology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1346-4280
PublisherJAPANESE SOC LYMPHORETICULAR TISSUE RESEARCH
Support Open AccessYes
CountryJapan
TypeJournal
Convergefrom 2006 to 2016, from 2019 to 2024
AbbreviationJ CLIN EXP HEMATOP / J. Clin. Exp. Hematop.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNAGOYA UNIV GRAD SCH MEDICINE, HIGH-TECHNOLOGY APPLICATION MEDICINE, CLINICAL PATHOPHYSI, NAGOYA 466-8550, JAPAN

Aims and Scopes

The Journal of Clinical and Experimental Hematopathology primarily focuses on advancing the understanding and treatment of hematologic malignancies. It serves as a platform for sharing innovative research findings, clinical experiences, and insights into the pathology of blood-related disorders, particularly lymphomas and leukemias.
  1. Hematologic Malignancies Research:
    The journal emphasizes research on various hematologic malignancies, including lymphomas, leukemias, and plasma cell disorders. It covers both clinical and experimental studies that contribute to the understanding of these diseases.
  2. Clinical Case Reports and Reviews:
    A significant portion of the journal includes case reports and literature reviews that provide insights into rare and complex cases, thereby enhancing clinical knowledge and guiding treatment strategies.
  3. Pathological Insights and Diagnostics:
    The journal highlights the importance of pathology in diagnosing hematologic disorders. It publishes studies focusing on histopathological evaluations, immunohistochemistry, and molecular techniques that assist in accurate diagnosis.
  4. Therapeutic Advances and Clinical Trials:
    Research on new therapeutic approaches, including novel drug treatments and clinical trial outcomes, is a core focus. The journal aims to disseminate findings that can influence treatment protocols and improve patient outcomes.
  5. Tumor Microenvironment and Immune Response:
    There is a growing emphasis on the role of the tumor microenvironment and immune interactions in hematologic diseases. The journal explores how these factors affect disease progression and treatment responses.
The Journal of Clinical and Experimental Hematopathology has been evolving, with several themes emerging as increasingly prominent in recent publications. This section outlines the trending and emerging scopes that reflect the current interests and advancements in the field.
  1. Precision Medicine and Targeted Therapies:
    There is a significant trend towards research focused on precision medicine and targeted therapies for hematologic malignancies. This includes studies on specific genetic mutations, biomarkers, and tailored treatment approaches that enhance efficacy and minimize toxicity.
  2. Immunotherapy and CAR T-cell Therapy:
    Immunotherapy, particularly CAR T-cell therapy, is gaining prominence in the journal's publications. Research exploring the mechanisms, efficacy, and safety of these therapies is increasingly relevant as they become standard treatment options for various hematologic cancers.
  3. Tumor Microenvironment Studies:
    Emerging themes related to the tumor microenvironment, including the interplay between tumor cells and immune cells, are becoming a focal point. This research is crucial for understanding disease progression and developing new therapeutic strategies.
  4. Patient-Centered Outcomes and Quality of Life:
    Research that addresses patient perspectives, treatment satisfaction, and quality of life is on the rise. This trend highlights the importance of incorporating patient-reported outcomes into clinical practice and research.
  5. Novel Biomarkers for Diagnosis and Prognosis:
    The discovery and validation of novel biomarkers for the diagnosis and prognosis of hematologic malignancies are increasingly featured. Such studies are essential for improving diagnostic accuracy and tailoring treatment strategies.

Declining or Waning

While the Journal of Clinical and Experimental Hematopathology maintains a broad focus on hematologic disorders, certain themes have begun to decline in prominence. This section highlights these waning scopes based on recent publication trends.
  1. Basic Laboratory Techniques:
    There appears to be a declining focus on basic laboratory techniques and methodologies compared to more advanced and specialized studies. Research that centers solely on traditional laboratory methods without novel insights or applications has become less common.
  2. Generalized Reviews without Novel Insights:
    The journal has seen a decrease in generalized review articles that do not provide new perspectives or significant updates on existing knowledge. There is a trend towards more focused reviews that address specific questions or emerging issues.
  3. Older Treatment Protocols:
    Research centered around older treatment protocols, especially those that have been largely replaced by newer regimens or therapies, is becoming less frequent. The journal is shifting towards studies that investigate contemporary treatment strategies and their outcomes.
  4. Epidemiological Studies without Clinical Relevance:
    Epidemiological studies that lack direct clinical relevance or applicability to current treatment practices are being published less frequently. The focus is moving towards studies that bridge the gap between epidemiology and clinical application.

Similar Journals

SEMINARS IN HEMATOLOGY

Driving Excellence in Hematology Education and Practice.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0037-1963Frequency: 4 issues/year

SEMINARS IN HEMATOLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic journal dedicated to the field of hematology. Established in 1964, this journal has built a robust reputation over its nearly six-decade history, now recognized as a Q1 journal in Hematology with an impressive impact factor reflective of its high relevance and citation frequency within the academic community. Residents and scholars can access meticulously curated articles that address innovative research, clinical practices, and advancements in the understanding of blood disorders and treatment methodologies. The journal, ranked #36 out of 137 in the Scopus Medicine Hematology category, showcases cutting-edge research, ensuring its contributions are crucial for professionals, researchers, and students striving to stay at the forefront of the hematology field. Although not an Open Access journal, SEMINARS IN HEMATOLOGY continues to unite a global audience dedicated to advancing the science and clinical practices in hematology.

Hematology Reports

Fostering collaboration in hematological research.
Publisher: MDPIISSN: 2038-8322Frequency: 4 issues/year

Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.

Egyptian Journal of Haematology

Shaping the Landscape of Hematology in the Middle East
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

Turkish Journal of Pathology

Fostering Collaboration in Pathology Research
Publisher: FEDERATION TURKISH PATHOLOGY SOCISSN: 1018-5615Frequency: 3 issues/year

Turkish Journal of Pathology, published by the Federation Turkish Pathology Society, stands as a vital platform for disseminating high-quality research in the field of pathology and forensic medicine. With an ISSN of 1018-5615 and an E-ISSN of 1309-5730, this journal has been an open-access publication since 2013, ensuring that cutting-edge findings are readily available to the global community. Based in Turkey, it aims to contribute significantly to the advancement of pathology as it converges from 2010 to 2024, currently holding a Q3 quartile ranking in its category according to 2023 metrics. As it ranks #129 out of 208 in the Scopus database for Medicine, Pathology, and Forensic Medicine, it offers researchers, professionals, and students invaluable insights and innovative studies that address critical developments in the field. The Turkish Journal of Pathology fosters collaboration and knowledge-sharing, making it an essential resource for anyone involved in pathology research and practice.

Journal of Hematopathology

Advancing knowledge in hematopathology.
Publisher: SPRINGER HEIDELBERGISSN: 1868-9256Frequency: 4 issues/year

The Journal of Hematopathology, published by SPRINGER HEIDELBERG, serves as a vital resource in the fields of hematology, histology, and pathology. Established in 2008, this peer-reviewed journal aims to foster the exchange of knowledge among researchers, clinicians, and students by publishing original articles, reviews, and case studies that contribute to the understanding of hematopathological disorders. While the journal currently ranks in the fourth quartile in various categories including hematology and histology, it positions itself as a platform for emergent research and insights, addressing the evolving landscape of blood-related diseases. Although not an open access journal, it provides crucial access to research findings for professionals looking to stay abreast of developments in pathologic diagnostics and therapeutic strategies. As it continues to grow, the journal remains committed to enhancing the knowledge base and scientific discourse in hematopathology.

International Journal of Laboratory Hematology

Connecting research and practice for the future of laboratory hematology.
Publisher: WILEYISSN: 1751-5521Frequency: 6 issues/year

The International Journal of Laboratory Hematology, published by WILEY, serves as a vital resource in the field of hematology, delivering high-quality research findings and innovations within laboratory practices since its inception in 2007. This journal, accessible under Open Access options, showcases cutting-edge studies that span critical aspects of biochemistry and clinical laboratory methodologies. With a notable impact factor reflected in its Q2 and Q3 rankings across various categories—such as Biochemistry (medical) and Hematology—this journal stands out within the Scopus rankings, positioning itself within the 60th and 59th percentiles of its respective fields. Situated in the United Kingdom, the journal's objectives lie in disseminating pivotal research that enhances our understanding of hematological disorders and laboratory techniques, making it an essential tool for researchers, professionals, and students alike who are committed to advancing the science of laboratory hematology and its applications.

PATHOLOGY INTERNATIONAL

Innovating Insights for a Healthier Tomorrow
Publisher: WILEYISSN: 1320-5463Frequency: 12 issues/year

PATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Exploring Breakthroughs in Blood Disorders
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

Rare Tumors

Championing rare tumor research for a brighter future.
Publisher: SAGE PUBLICATIONS LTDISSN: 2036-3605Frequency: 1 issue/year

Rare Tumors, published by SAGE Publications Ltd, is a premier open-access journal dedicated to advancing the understanding and research of rare neoplasms. With the ISSN 2036-3605 and E-ISSN 2036-3613, this journal provides a vital platform for sharing innovative research findings and clinical insights since its inception in 2009. Situated in Italy, Rare Tumors has a converged publication timeline from 2010 to 2024 and aims to foster a supportive community for researchers and professionals in the oncology and histology fields. It has achieved a notable Q3 ranking in Oncology and Q4 in Histology as of 2023, reflecting its crucial role in bridging the knowledge gap in these specialized areas. Despite its relatively humble Scopus ranks, the journal's open-access model ensures that vital information reaches a broad audience, including those in academia, clinical practice, and beyond. It aspires to not only document rare tumor cases but also stimulate dialogue on their diagnosis, treatment, and management strategies, making it an indispensable resource for anyone dedicated to tackling the challenges posed by rare tumors.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Fostering Excellence in Pathology and Clinical Practice
Publisher: OXFORD UNIV PRESS INCISSN: 0002-9173Frequency: 12 issues/year

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.